Internet of Events Leaderboard Traders Markets Hot Bets Surveillance Pricing

Log in Get Access

Accrue
/Home
/Manifold Markets
/Will any NLRP3 inhibitor drug be approved in 2023?

ManifoldResolved: NOBINARY · cpmm-1

Will any NLRP3 inhibitor drug be approved in 2023?

Yes5%

Yes Pool

$312

No Pool

$16

Resolution

NO

Probability

5%

Volume$260

24h Volume$0

Liquidity$70

Traders4

CreatorSarah

ClosesDec 31, 2024

View on Manifold →Compare Across Platforms →

Accrue© 2026

Internet of Events Leaderboard Traders Markets Hot Bets Surveillance

The Intelligence Terminal for Prediction Markets

Terms Privacy Risk Disclosure Cookies Disclaimer Acceptable Use